The SmallCapRelations Newsletter Where Promising Small-cap Market Plays Meet Forward-thinking Investors

The SmallCapRelations Newsletter Newsletter Archives

SmallCapRelationsSpotlight Company

Lantern Pharma Inc. (NASDAQ: LTRN)

Investment Considerations Lantern Pharma’s AI-driven RADR® platform integrates over 200 billion oncology-specific data points and underpins every stage of its precision oncology pipeline. The company has three lead drug candidates in clinical development, targeting major oncology markets including NSCLC, TNBC, and NHL. Starlight Therapeutics extends Lantern’s footprint into brain and CNS cancers, including pediatric indications … Continue reading “Lantern Pharma Inc. (NASDAQ: LTRN)”

View Profile

Lantern Pharma Inc.

Latest Press Releases

Filter Releases
Filters
Sector



Symbol Release Time Source
{{ release.qmtopics.qmsymbol[0].symbol }} {{ release.headline }} {{ release.datetime | amDateFormat:'hh:mm A'}} {{ release.source }}
IBN (InvestorBrandNetwork)

SmallCapRelations is part of the IBN (InvestorBrandNetwork).

SmallCapRelations (SCR) exists to enhance the communication between public entities and stakeholders through accurate, timely and informative messaging solutions. We also specialize in the unique communication needs of private companies planning to go public. With a substantial staff of corporate communication professionals, SCR builds a framework that rapidly conveys your brand's messaging to potential shareholders, clients, analysts, media and the general public.

Other brands within the network include:
CannabisNewsWire (CNW)
CryptoCurrencyWire (CCW)
MissionIR (MIR)
NetworkNewsWire (NNW)
QualityStocks (QS)
QualityStocksTwits
StocksToBuyNow (STBN)
SeriousTraders
Tip.us
TraderPower (TP)
Interested in a live, online demonstration?

Schedule a LIVE Demo